MELANIE GOLLIVER: Open Payments
NPI 1043979024 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 40 payments from 10 companies in 2025. Trend: 2023 $1,001 · 2024 $680 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $282 |
| Amgen Inc. | 11 | $141 |
| Novo Nordisk Inc | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Lundbeck LLC | 1 | $28 |
| ABBVIE INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FARXIGA, OTEZLA, BREZTRI, Kerendia, Ozempic, AIRSUPRA, GEMTESA, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
